XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEET (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets:    
Cash and Cash Equivalents $ 282,757 $ 706,350
Cash - Restricted (Note 6) 98,970 70,124
Accounts Receivable 485,542 805,809
Inventories (Note 3) 403,038 407,549
Prepaids Expenses 12,718 7,980
Total Current Assets 1,283,025 1,997,812
Property & Equipment - net (Note 4) 271,564 164,068
Other Assets:    
Intangible Assets - net (Note 5)) 2,934,187 3,026,564
Deferred Financing Costs - net (Note 6) 457,666 542,116
Deposits 16,947 2,543
Total Other Assets 3,408,801 3,571,223
Total Assets 4,963,390 5,733,103
Current Liabilities:    
Accounts Payable and Accrued Expenses 309,543 383,349
Accrued Interest on Convertible Notes (Note 6) 84,567 211,194
Accrued Officers Compensation (Note 9) 27,000 25,000
Common Stock to be Issued (Note 12) 49,256 150,871
Customer Deposits 9,765 14,105
Derivative Liability (Note 7) 5,914,197 7,665,502
Total Current Liabilities 6,394,328 8,450,021
Convertible Notes Payable, net of discount of $4,928,590 and $5,003,558 at March 31, 2014 and December 31, 2013, respectively (Note 6) 145,410 70,442
Total Long-term Liabilities 145,410 70,442
Total Liabilities 6,539,738 8,520,463
Commitments and Contingencies      
Stockholders' Equity ( Deficiency):    
Cumulative Convertible Series A Preferred Stock; par value $0.01, 1,000,000 shares authorized; 510,000 shares issued and outstanding at March 31, 2014 and December 31, 2013 5,100 5,100
Cumulative Convertible Series B Preferred Stock; $1,000 stated value; 7.5% Cumulative dividend; 4,000 shares authorized; none issued and outstanding at March 31, 2014 and December 31, 2013      
Common stock; par value $0.01, 200,000,000 shares authorized; 80,201,520 and 79,867,217 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively. 802,015 798,672
Additional Paid-in Capital 16,979,835 15,674,958
Accumulated Deficit (19,363,298) (19,266,090)
Total Stockholders' Deficiency (1,576,348) (2,787,360)
Total Liabilities and Stockholders' Deficiency $ 4,963,390 $ 5,733,103